Acadian Asset Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-62,800
Closed -$1.65M 1923
2022
Q1
$1.65M Buy
62,800
+15,164
+32% +$370K 0.01% 706
2021
Q4
$1.13M Buy
47,636
+2,876
+6% +$71K ﹤0.01% 805
2021
Q3
$1.12M Sell
44,760
-4,189
-9% -$107K ﹤0.01% 812
2021
Q2
$1.27M Sell
48,949
-25,002
-34% -$680K ﹤0.01% 845
2021
Q1
$1.9M Sell
73,951
-49,991
-40% -$1.28M 0.01% 748
2020
Q4
$2.48M Buy
123,942
+22,666
+22% +$444K 0.01% 701
2020
Q3
$1.74M Sell
101,276
-17,820
-15% -$337K 0.01% 708
2020
Q2
$2.6M Buy
119,096
+19,580
+20% +$448K 0.01% 664
2020
Q1
$2.3M Buy
99,516
+71,549
+256% +$2.08M 0.01% 566
2019
Q4
$924K Buy
27,967
+25,052
+859% +$803K ﹤0.01% 901
2019
Q3
$93K Buy
+2,915
New +$85K ﹤0.01% 1506
2017
Q1
Sell
-75,280
Closed -$2.62M 1835
2016
Q4
$2.62M Buy
+75,280
New +$2.96M 0.01% 536
2015
Q2
Sell
-103,433
Closed -$4.08M 1542
2015
Q1
$4.08M Sell
103,433
-147,311
-59% -$5.43M 0.02% 426
2014
Q4
$9.04M Buy
+250,744
New +$8.42M 0.04% 308

Other funds holding NTUS

Acadian Asset Management's NTUS Position: Q2 2022 in Review

Acadian Asset Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 62,800 shares — an estimated $1.65M sold.

Acadian Asset Management first reported a position in NTUS in Q4 2014 and held it in 14 quarters. The position peaked at $9.04M in Q4 2014. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Acadian Asset Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Acadian Asset Management sold 62,800 Natus Medical Inc shares in Q2 2022, an estimated $1.65M.
  • Acadian Asset Management first reported a position in Natus Medical Inc in Q4 2014 and held it in 14 quarters.
  • Acadian Asset Management's Natus Medical Inc position peaked at $9.04M in Q4 2014.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Acadian Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.